BAUSCH & LOMB's GENERIC MINOXIDIL IS ON ITS WAY TO MARKET; Nationwide Shipping of Minoxidil Begins; Company Implements a Varied Branding Strategy.ROCHESTER, N.Y.--(BUSINESS WIRE)--May 9, 1996--Bausch & Lomb's (NYSE/BOL) U.S. Pharmaceutical business announced that today it began nationwide shipping of 2% Minoxidil Minoxidil Definition Minoxidil is a drug available in two forms to treat different conditions. Oral minoxidil is used to treat high blood pressure and the topical solution form is used to treat hair loss and baldness. Topical Solution, the generic form of the hair-regrowth drug Rogaine(R), to wholesalers. Bausch & Lomb Pharmaceuticals, Inc. is marketing the over-the-counter (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). ) product under its Healthguard label. Healthguard is the trademark the company uses to market several of its OTC ophthalmic products. Minoxidil, under the Healthguard label, will be distributed through wholesalers to independent pharmacies and small drugstore chains. Bausch & Lomb is entering the OTC market Noun 1. OTC market - a stock exchange where securities transactions are made via telephone and computer rather than on the floor of an exchange over-the-counter market with its male-version of Minoxidil, a week after a U.S. District Court judge lifted a temporary restraining order temporary restraining order: see injunction. against the OTC marketing of Minoxidil, and upheld the Food and Drug Administration's (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) decision to deny three-year exclusivity to Pharmacia & Upjohn, Inc., the makers of Rogaine. Bausch & Lomb received its original FDA clearance to manufacture and begin OTC marketing of Minoxidil on April 9, 1996. In addition to the Healthguard product, Bausch & Lomb has secured business in the private label and house brand segment for Minoxidil. The company will begin shipping the private-labeled and house-branded products to large retail drugstore chains upon availability of customized labeling. "This is an exciting new area of pharmaceutical treatment for Bausch & Lomb," said Thomas M. Riedhammer, senior vice president, Bausch & Lomb Worldwide Pharmaceutical, Surgical and Hearing Care Products. "While hair-regrowth is not one of Bausch & Lomb's core businesses, the quality manufacturing of sterile and non-sterile solutions, suspensions and ointments ointments, n.pl semisolid, non–water-based treatments that are not water-soluble and that create protective films to prevent dehydration of the skin. is one of our distinctive core competencies. "Minoxidil, which is a non-sterile solution, represents a good, opportunistic fit for our pharmaceutical facility, as well as a solid commercial opportunity." Bausch & Lomb, the global healthcare and optics company, known for its contact lenses contact lenses contact npl → verres mpl de contact contact lenses contact npl → Kontaktlinsen pl contact lenses npl , lens care, and sunglasses, has been manufacturing and marketing pharmaceutical products, primarily for ophthalmic uses, since 1987. Bausch & Lomb Pharmaceuticals, Inc., a subsidiary headquartered in Tampa, Florida, produces both prescription and OTC medications. Bausch & Lomb, the company, is a global leader in selected healthcare and optics markets. Its products are distributed in more than 70 countries throughout the world. Headquartered in Rochester, New York This article is about the city of Rochester in Monroe County. For the town in Ulster County, see Rochester, Ulster County, New York. Rochester, once known as The Flour City, and more recently as The Flower City or , the company has 14,000 employees worldwide. CONTACT: Investor Relations Investor relations The process by which the corporation communicates with its investors. Contact: Frank Jepson 716-338-6025 or Ruth Sleeman 716-338-8718 or For further information contact: Holly Echols 716-338-8064 office 716-473-7104 home 800-405-5314 pager or Barbara Kelley 716-338-5386 office 716-621-7141 home or Marika Thiessen 813-975-7700 ext. 7077 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion